These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 73137)

  • 21. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
    Schultz KR; Klarnet JP; Gieni RS; HayGlass KT; Greenberg PD
    Science; 1990 Aug; 249(4971):921-3. PubMed ID: 2118273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term culture of tumour-specific cytotoxic T cells.
    Gillis S; Smith KA
    Nature; 1977 Jul; 268(5616):154-6. PubMed ID: 145543
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
    Plata F; Tilkin AF; Lévy JP; Lilly F
    J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
    Doig D; Chesebro B
    J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes.
    Miyazawa M; Nishio J; Chesebro B
    J Exp Med; 1988 Nov; 168(5):1587-605. PubMed ID: 3141552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens.
    Prat M; Rogers MJ; Appella E
    J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiviral antibodies inhibit the lysis of tumour cells by anti-H--2 sera.
    Henning R; Schrader JW; Edelman GM
    Nature; 1976 Oct; 263(5579):689-91. PubMed ID: 185524
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 30. The availability for recognition of normal H-2 antigens by cytotoxic T lymphocytes on a Rauscher-virus-transformed cell, RBL-5A.
    Watson A; Zarling DA; Bach FH
    Scand J Immunol; 1979; 10(4):353-8. PubMed ID: 93777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of GIX-linked minor histocompatibility antigens by H-2-restricted cytotoxic T lymphocytes from C57BL/6-GIX+ mice: an approach to mapping the genes controlling GIX.
    Green WR
    J Immunol; 1982 Feb; 128(2):920-5. PubMed ID: 6172516
    [No Abstract]   [Full Text] [Related]  

  • 32. H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.
    Britt WJ; Chesebro B
    J Exp Med; 1983 Jun; 157(6):1736-45. PubMed ID: 6406638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression by Friend leukemia virus is H-2 restricted by alloreactive T lymphocytes.
    Kumar V; Bennett M
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2415-9. PubMed ID: 313055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 35. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
    Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
    [No Abstract]   [Full Text] [Related]  

  • 36. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
    Longstreth JD; Ihle JN; Hanna MG
    Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
    [No Abstract]   [Full Text] [Related]  

  • 37. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 39. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive transfer of delayed-type hypersensitivity to Sendai virus. I. Induction of two different subsets of T lymphocytes which differ in H-2 restriction as well as in the Lyt phenotype.
    Ertl HC
    Cell Immunol; 1981 Jul; 62(1):38-49. PubMed ID: 6167372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.